203 related articles for article (PubMed ID: 34725898)
1. Nepetin Acts as a Multi-Targeting Inhibitor of Protein Tyrosine Phosphatases Relevant to Insulin Resistance.
Yoon SY; Ahn D; Kim JK; Seo SO; Chung SJ
Chem Biodivers; 2022 Jan; 19(1):e202100600. PubMed ID: 34725898
[TBL] [Abstract][Full Text] [Related]
2. Methyl Syringate Stimulates Glucose Uptake by Inhibiting Protein Tyrosine Phosphatases Relevant to Insulin Resistance.
Ahn D; Kwon J; Song S; Lee J; Yoon S; Chung SJ
Life (Basel); 2023 Jun; 13(6):. PubMed ID: 37374154
[TBL] [Abstract][Full Text] [Related]
3. Phloridzin Acts as an Inhibitor of Protein-Tyrosine Phosphatase MEG2 Relevant to Insulin Resistance.
Yoon SY; Yu JS; Hwang JY; So HM; Seo SO; Kim JK; Jang TS; Chung SJ; Kim KH
Molecules; 2021 Mar; 26(6):. PubMed ID: 33799458
[TBL] [Abstract][Full Text] [Related]
4. Identification of chebulinic acid as a dual targeting inhibitor of protein tyrosine phosphatases relevant to insulin resistance.
Yoon SY; Kang HJ; Ahn D; Hwang JY; Kwon SJ; Chung SJ
Bioorg Chem; 2019 Sep; 90():103087. PubMed ID: 31284101
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma.
Karaca Atabay E; Mecca C; Wang Q; Ambrogio C; Mota I; Prokoph N; Mura G; Martinengo C; Patrucco E; Leonardi G; Hossa J; Pich A; Mologni L; Gambacorti-Passerini C; Brugières L; Geoerger B; Turner SD; Voena C; Cheong TC; Chiarle R
Blood; 2022 Feb; 139(5):717-731. PubMed ID: 34657149
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of protein tyrosine phosphatase non-receptor type 2 by PTP inhibitor XIX: Its role as a multiphosphatase inhibitor.
Le HTT; Cho YC; Cho S
BMB Rep; 2017 Jun; 50(6):329-334. PubMed ID: 28228214
[TBL] [Abstract][Full Text] [Related]
7. Potent inhibition of protein tyrosine phosphatases by copper complexes with multi-benzimidazole derivatives.
Li Y; Lu L; Zhu M; Wang Q; Yuan C; Xing S; Fu X; Mei Y
Biometals; 2011 Dec; 24(6):993-1004. PubMed ID: 21618062
[TBL] [Abstract][Full Text] [Related]
8. Targeting protein tyrosine phosphatases for anticancer drug discovery.
Scott LM; Lawrence HR; Sebti SM; Lawrence NJ; Wu J
Curr Pharm Des; 2010 Jun; 16(16):1843-62. PubMed ID: 20337577
[TBL] [Abstract][Full Text] [Related]
9. Terminalin from African Mango (
Yoon SY; Kim J; Lee BS; Baek SC; Chung SJ; Kim KH
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204821
[TBL] [Abstract][Full Text] [Related]
10. Identification of protein tyrosine phosphatases and dual-specificity phosphatases in mammalian spermatozoa and their role in sperm motility and protein tyrosine phosphorylation.
González-Fernández L; Ortega-Ferrusola C; Macias-Garcia B; Salido GM; Peña FJ; Tapia JA
Biol Reprod; 2009 Jun; 80(6):1239-52. PubMed ID: 19211810
[TBL] [Abstract][Full Text] [Related]
11. [Research progress of several protein tyrosine phosphatases in diabetes].
Chen M; Sun JP; Liu J; Yu X
Sheng Li Xue Bao; 2010 Apr; 62(2):179-89. PubMed ID: 20401454
[TBL] [Abstract][Full Text] [Related]
12. T cell protein tyrosine phosphatase (TCPTP) deficiency in muscle does not alter insulin signalling and glucose homeostasis in mice.
Loh K; Merry TL; Galic S; Wu BJ; Watt MJ; Zhang S; Zhang ZY; Neel BG; Tiganis T
Diabetologia; 2012 Feb; 55(2):468-78. PubMed ID: 22124607
[TBL] [Abstract][Full Text] [Related]
13. Dinuclear copper complexes of organic claw: potent inhibition of protein tyrosine phosphatases.
Ma L; Lu L; Zhu M; Wang Q; Gao F; Yuan C; Wu Y; Xing S; Fu X; Mei Y; Gao X
J Inorg Biochem; 2011 Sep; 105(9):1138-47. PubMed ID: 21708098
[TBL] [Abstract][Full Text] [Related]
14. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
Rao GS; Ramachandran MV; Bajaj JS
J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
Sun LP; Gao LX; Ma WP; Nan FJ; Li J; Piao HR
Chem Biol Drug Des; 2012 Oct; 80(4):584-90. PubMed ID: 22805439
[TBL] [Abstract][Full Text] [Related]
16. Ginkgolic acid as a dual-targeting inhibitor for protein tyrosine phosphatases relevant to insulin resistance.
Yoon SY; Lee JH; Kwon SJ; Kang HJ; Chung SJ
Bioorg Chem; 2018 Dec; 81():264-269. PubMed ID: 30153591
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of FGFR3 by PTPN1 and PTPN2.
St-Germain JR; Taylor P; Zhang W; Li Z; Ketela T; Moffat J; Neel BG; Trudel S; Moran MF
Proteomics; 2015 Jan; 15(2-3):419-33. PubMed ID: 25311528
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of insulin responsiveness by nitric oxide-mediated inactivation of protein-tyrosine phosphatases.
Hsu MF; Meng TC
J Biol Chem; 2010 Mar; 285(11):7919-28. PubMed ID: 20064934
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity optimization of azepane-containing derivatives as PTPN2/PTPN1 inhibitors.
Zheng J; Zhang Z; Ding X; Sun D; Min L; Wang F; Shi S; Cai X; Zhang M; Aliper A; Ren F; Ding X; Zhavoronkov A
Eur J Med Chem; 2024 Apr; 270():116390. PubMed ID: 38604096
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of pro-inflammatory cytokine signalling by protein tyrosine phosphatases in pancreatic β-cells.
Stanley WJ; Trivedi PM; Sutherland AP; Thomas HE; Gurzov EN
J Mol Endocrinol; 2017 Nov; 59(4):325-337. PubMed ID: 28827413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
